Total joint arthroplasty in patients with chronic infectious liver disease
The opportunity for total joint arthroplasty (TJA) in patients with chronic infectious liver disease is rapidly expanding. This is the product of both superior survival of chronic hepatitis patients, evolving implant technologies, and improvement of techniques in TJA. Unfortunately, treating this gr...
Main Authors: | Jeremy N. Truntzer, MD, Kalpit N. Shah, MD, Derek R. Jenkins, MD, Lee E. Rubin, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-06-01
|
Series: | Arthroplasty Today |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352344115000515 |
Similar Items
-
Total knee arthroplasty in a patient with hypofibrinogenemia
by: Christopher R. Nacca, MD, et al.
Published: (2016-12-01) -
The Association Between Clopidogrel and Gastrointestinal Bleeding After Primary Total Joint Arthroplasty
by: David Kugelman, MD, et al.
Published: (2021-06-01) -
Association of hepatitis B infection with high-risk complications in total joint arthroplasty
by: Jin Wang, et al.
Published: (2019-04-01) -
The Impact of Hepatitis C and Liver Disease on Risk of Complications After Total Hip and Knee Arthroplasty: Analysis of Administrative Data From Louisiana and Texas
by: Brett Salomon, MD, et al.
Published: (2021-02-01) -
Health care economics and total joint arthroplasty
by: Mark J. Spangehl, MD
Published: (2017-03-01)